|
As Hoped, Biotech And Drugs March To Their Own Beat
|
|
Mannkind
|
Aug 07, 2012 08:48AM
|
|
As of April 10,2012
|
|
Mannkind
|
Apr 16, 2012 03:54PM
|
|
AstraZeneca to Cut 2,300 Sales Jobs as Research to Narrow
|
|
Mannkind
|
Mar 21, 2013 10:13AM
|
|
Audiocast: Big volume in MannKind
|
|
Mannkind
|
Apr 09, 2013 10:12AM
|
|
Australian Design Certification Round-Up 21 June 2012
|
2
|
Mannkind
|
Jun 21, 2012 10:15AM
|
|
Baba,
|
|
Mannkind
|
Oct 16, 2012 09:55AM
|
|
Bank of America Healthcare Conference
|
1
|
Mannkind
|
May 08, 2013 09:38AM
|
|
Basalin?
|
1
|
Mannkind
|
Aug 14, 2012 09:42AM
|
|
Behold
|
4
|
Mannkind
|
Mar 18, 2013 09:48AM
|
|
Best 5 & Worst 5 Biotech Stocks:
|
|
Mannkind
|
May 13, 2013 08:28AM
|
|
Big Pharma’s Antigravity Pricing Could Come To Earth
|
|
Mannkind
|
Mar 21, 2012 12:11PM
|
|
Bio-Wire Weekly (4/1/13 – 4/5/13)
|
1
|
Mannkind
|
Apr 08, 2013 11:45AM
|
|
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes M
|
|
Mannkind
|
Jun 18, 2013 09:02AM
|
|
Bionic eye maker has vision of the future
|
|
Mannkind
|
May 07, 2013 07:31PM
|
|
BioPharma Catalyst Trade Pick Of The Week: Biodel
|
|
Mannkind
|
Jul 30, 2013 09:16AM
|
|
Biopharmaceutical Companies Developing Insulin Pills May Bring High Profits
|
|
Mannkind
|
Feb 21, 2013 09:57AM
|
|
Biotech: Hedging While Speculating
|
2
|
Mannkind
|
Mar 29, 2013 06:40AM
|
|
Biotech’s Hottest Trend — Dilution
|
1
|
Mannkind
|
Oct 17, 2012 09:50PM
|
|
Brinson Patrick initiates coverage on MannKind Corp...
|
|
Mannkind
|
Dec 03, 2012 09:57AM
|
|
Bristol Myers Squibb (BMY) Nabs Diabetes Player Amylin Pharmaceuticals (AMLN). W
|
2
|
Mannkind
|
Jul 02, 2012 02:48PM
|
